[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_596 

# __Thrombotomodulin__

## Category to which it belongs

* [Efforts include RNA monitoring, occupant exposure modeling, targeted messages, adoption of principles, copper coating, and more.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_304.md)

## Closest similar item

* [AI-powered applications for diagnosis and treatment](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1435.md)
* [Blood types](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_597.md)
* [Proteolysis of S protein by cathepsin](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_593.md)
* [Non-Pharmaceutical Interventions (NPIs)](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_666.md)
* [Robotics in healthcare](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_809.md)
* [UVGI](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_315.md)
* [Mobile chatbot applications](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1156.md)
* [ACE2 and TMPRSS2 inhibitors](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_595.md)
* [Virtual reality-based therapy](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_2740.md)
* [Using wearables to manage symptoms and identify overexertion in individuals with long COVID](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_949.md)

## Benefits linked to a risk

* [Thrombotic complications](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_594.md)

## Risks possibly mitigated by this Mitigation

* [Tissue tropism](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_428.md)

